The Global Plasma Fractionation Market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing prevalence of chronic diseases among all age groups such as immunological disorders graves diseases along with increasing demand for immunoglobulins for the treatment of chronic diseases. Additionally, growing prevalence of blood and respiratory disorders due to and growing advancement in technology to cure the diseases has significantly increased the demand for plasma fractionation across different parts of the globe. Additionally, growing geriatric population across the globe which is susceptible to different kinds of chronic diseases is further expected to increase the demand for plasma fractionation, thereby fuelling the market growth through 2028. Besides, growing awareness about the advantages of using plasma fractions for the diagnosis of chronic diseases across the globe is further expected to support the plasma fractionation market during the forecast period. Furthermore, increasing research and development activities related to immunoglobulin is further expected to increase the demand for dental contouring. According to the Statista, as of 2022, around 51 percent of patients with Bernard Soulier syndrome were female, while to 49 percent were male.

Growing Prevalence of Immunodeficiency disorder

 

Increasing incidence of blood and immune disorders, off label usage of critical plasma products like albumins, immunoglobulins is the main factors which will boost the market growth during the forecast period. Similarly, rising use of immunoglobulins and alpha-1-antitrypsin in the medical sectors as a plasma fraction will propel the growth of the market. Similarly, increasing demand for plasma related therapies is important for the treatment of new diseases. In the present years, usage of protease inhibitors like alpha-1-antitrypsin protein is increased for the treatment of lung diseases and hepatic diseases, this in turn is expected create a lucrative growth for the market in the forecast period. For instance, according to the March 2021 report of the Alzheimer’s Association, approximately 6.2 million people of age 65 years and more are living with Alzheimer’s-related dementia in the United States.

 

Development of New Technologies

Major players are investing in different therapies that will produce reliable results. Manufactures are focusing on new therapies such as IgA, Plasmin and Ceruloplasmin. This, in turn, is expected to create a lucrative growth in the forecast period. A rapid chang in healthcare sector along with continuous technological innovation shall accelerate demand for plasma fractionation in the developing countries like North America. In 2019, there were around 195,263 people worldwide who had been diagnosed with hemophilia and 80,302 who had been diagnosed with von Willebrand disease.

 


Download Free Sample Report

Market Segmentation

The global plasma fractionation market can be segmented by product, method, application, end user and by region. Based on product, the market can be segmented into Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, and Others. Based on method, the market can be differentiated into Centrifugation, Depth Filtration, Chromatography, and Others. Based on application, the market can be grouped into Neurology, Hematology, Oncology, Immunology, and Others. Based on end user, the market can be segmented into Hospitals & Clinics, Academic & Research Institutes, Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global plasma fractionation market on account of the growing demand for new therapies for the treatment of chronic diseases in the country.

 

Market Players

Grifols S.A., Octapharma AG, Intas Pharmaceuticals Ltd, LFB S.A., Takeda Pharmaceutical Company Limited, CSL Limited, Biotest AG, Kedrion S.p.A, Bio Products Laboratory Ltd.’, Bharat Serums and Vaccines Limited are some of the leading players operating in the Global Plasma Fractionation Market.

Recent Development

  • For instance, in March 2021, according to the WHO Model List of essential medicines includes several plasma-derived medicinal products (PDMPs), identifying them as drugs thought to be the most efficient and secure for addressing the most essential requirements in a health system and provide the best guidelines on increased supply of PDMPs in low & middle-income countries
  • For instance, in April 2020, to create a viable plasma-derived medication for treating COVID-19, CSL Behring & Takeda Pharmaceutical Company Ltd. collaborated with Biotest, BPL, LFB, and Octapharma.
  • For instance, in April 2019, under a long-term initiative to support people with hemophilia, Grifols International SA, a supplier of plasma-derived therapeutics, provided blood clotting factor medications (100 million international units) for the treatment of hemophilic patients.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         By Product

·         By Method

·         By Application

·         By End User

·         By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Turkey; Egypt

Key companies profiled

Grifols S.A., Octapharma AG, Intas Pharmaceuticals Ltd, LFB S.A., Takeda Pharmaceutical Company Limited, CSL Limited, Biotest AG, Kedrion S.p.A, Bio Products Laboratory Ltd.’, Bharat Serums and Vaccines Limited

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global plasma fractionation market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Plasma Fractionation Market, By Product:

o      Albumin

o      Immunoglobulins

o      Coagulation Factors

o      Protease Inhibitors

o      Others

·         Plasma Fractionation Market, By Method:

o      Centrifugation

o      Depth Filtration

o      Chromatography

o      Others

  • Plasma Fractionation Market, By Application:

o      Neurology

o      Hematology

o      Oncology

o      Immunology

o      Others

·         Plasma Fractionation Market, By End User:

o      Hospitals & Clinics

o      Academic & Research Institutes

o      Others

·         Plasma Fractionation Market, By Region:

o      North America

§  United States

§  Canada

§  Mexico

o      Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o      Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o      South America

§  Brazil

§  Argentina

§  Colombia

o      Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Plasma Fractionation Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Plasma Fractionation Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Plasma Fractionation Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Product (Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, Others)

5.2.2.     By Method (Centrifugation, Depth Filtration, Chromatography, Others)

5.2.3.     By Application (Neurology, Hematology, Oncology, Immunology, Others)

5.2.4.     By End User (Hospitals & Clinics, Academic & Research Institutes, Others)

5.2.5.     By Region

5.2.6.     By Company (2022)

5.3.  Market Map

5.3.1.     By Product

5.3.2.     By Method

5.3.3.     By Application

5.3.4.     By End User

5.3.5.     By Region

6.    North America Plasma Fractionation Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product

6.2.2.     By Method

6.2.3.     By Application

6.2.4.     By End User

6.2.5.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Plasma Fractionation Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Product

6.3.1.2.2.             By Method

6.3.1.2.3.             By Application

6.3.1.2.4.             By End User

6.3.2.     Canada Plasma Fractionation Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Product

6.3.2.2.2.             By Method

6.3.2.2.3.             By Application

6.3.2.2.4.             By End User

6.3.3.     Mexico Plasma Fractionation Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Product

6.3.3.2.2.             By Method

6.3.3.2.3.             By Application

6.3.3.2.4.             By End User

7.    Europe Plasma Fractionation Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product

7.2.2.     By Method

7.2.3.     By Application

7.2.4.     By End User

7.2.5.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Plasma Fractionation Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product

7.3.1.2.2.             By Method

7.3.1.2.3.             By Application

7.3.1.2.4.             By End User

7.3.2.     Germany Plasma Fractionation Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product

7.3.2.2.2.             By Method

7.3.2.2.3.             By Application

7.3.2.2.4.             By End User

7.3.3.     United Kingdom Plasma Fractionation Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product

7.3.3.2.2.             By Method

7.3.3.2.3.             By Application

7.3.3.2.4.             By End User

7.3.4.     Italy Plasma Fractionation Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product

7.3.4.2.2.             By Method

7.3.4.2.3.             By Application

7.3.4.2.4.             By End User

7.3.5.     Spain Plasma Fractionation Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product

7.3.5.2.2.             By Method

7.3.5.2.3.             By Application

7.3.5.2.4.             By End User

8.    Asia-Pacific Plasma Fractionation Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product

8.2.2.     By Method

8.2.3.     By Application

8.2.4.     By End User

8.2.5.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Plasma Fractionation Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product

8.3.1.2.2.             By Method

8.3.1.2.3.             By Application

8.3.1.2.4.             By End User

8.3.2.     India Plasma Fractionation Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product

8.3.2.2.2.             By Method

8.3.2.2.3.             By Application

8.3.2.2.4.             By End User

8.3.3.     Japan Plasma Fractionation Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product

8.3.3.2.2.             By Method

8.3.3.2.3.             By Application

8.3.3.2.4.             By End User

8.3.4.     South Korea Plasma Fractionation Market Outlook